ArticleInternational journal of molecular sciences2025
Transmembrane Homodimers Interface Identification: Predicting Interface Residues in Alpha-Helical Transmembrane Protein Homodimers Using Sequential and Structural Features.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Most bitopic transmembrane proteins associate with one another through interface residues to form dimers, which facilitate or activate specific cellular functions. Therefore, accurately identifying interface residues in a given dimer is crucial for understanding its function and has been a challenging pursuit for many computational methods. These methods can be broadly categorized into two approaches: general-purpose ones for dimerization and specialized ones for interface residues. In this study, we develop a machine learning method that integrates both approaches by integrating sequential and structural features extracted from predicted structures and various domains. The results from cross-validation on a benchmark dataset show that our method, despite utilizing significantly fewer features, outperforms the state-of-the-art methods by more than three percentage points in performance, as measured by the F1 score. Furthermore, we evaluated the performance of the proposed model on a benchmark dataset as compared to the state-of-the-art multimeric structure predictors, including RoseTTAFold2, AlphaFold2Multimer, and PREDDIMER. The results show the superiority of the proposed model by outperforming all the other models, highlighting the effectiveness of integrating both structural and sequential features within the proposed framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.